US 8969296
TGFP-CAP peptide and its uses
granted A61KA61K38/00A61K38/1841
Quick answer
US patent 8969296 (TGFP-CAP peptide and its uses) held by CAREGEN CO., LTD. expires Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CAREGEN CO., LTD.
- Grant date
- Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K38/00, A61K38/1841, A61K8/64, A61P